Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2005
X-ray volume imaging in bladder radiotherapy verification
Ann M Henry, Julia Stratford, Claire McCarthy, et al.
The Journal of Biological Chemistry
|
December 5, 2022
Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80
Tara Kang-Pettinger, Kayleigh Walker, Richard Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2020
Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain
Rebekka Schairer, Gareth Hall, Ming Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial
Michael Brundage, Matthew R Sydes, Wendy R Parulekar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2026
Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis
Samir Abai, Moritz Fabian Danzer, Chalid Assaf, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Pierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Lancet (London, England)
|
November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
Padraig Warde, Malcolm Mason, Keyue Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2013
A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors
Balaji Venugopal, Richard Baird, Rebecca S Kristeleit, et al.
European Journal of Dermatology : EJD
|
May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
Martine Bagot, Baktiar Hasan, Sean Whittaker, et al.
The Journal of Allergy and Clinical Immunology
|
April 12, 2026
Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group
Joana Calvão, Adèle de Masson, Antonio Cozzio, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2005
X-ray volume imaging in bladder radiotherapy verification
Ann M Henry, Julia Stratford, Claire McCarthy, et al.
The Journal of Biological Chemistry
|
December 5, 2022
Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80
Tara Kang-Pettinger, Kayleigh Walker, Richard Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 26, 2020
Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain
Rebekka Schairer, Gareth Hall, Ming Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial
Michael Brundage, Matthew R Sydes, Wendy R Parulekar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 13, 2026
Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis
Samir Abai, Moritz Fabian Danzer, Chalid Assaf, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Pierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Lancet (London, England)
|
November 8, 2011
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
Padraig Warde, Malcolm Mason, Keyue Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2013
A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors
Balaji Venugopal, Richard Baird, Rebecca S Kristeleit, et al.
European Journal of Dermatology : EJD
|
May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
Martine Bagot, Baktiar Hasan, Sean Whittaker, et al.
The Journal of Allergy and Clinical Immunology
|
April 12, 2026
Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group
Joana Calvão, Adèle de Masson, Antonio Cozzio, et al.
Page
of 5